QA: Palvella Therapeutics INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001583648_2023_Palvella_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001583648, Palvella Therapeutics INC

  xvar xval
0 AssetsCurrent 73,424,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 16,992,000
3 remainder_Assets 5,074,000
4 LiabilitiesCurrent 36,583,000
5 LiabilitiesNoncurrent 30,978,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,351,795
9 ResearchAndDevelopmentExpense 54,726,706
10 remainder_Expenses 0
11 remainder_Revenues 27,761,563
12 remainder_NetIncome 9,940,124
13 remainder_ComprehensiveNetIncome -278,894
  yvar yval
0 Assets 95,490,000
1 Liabilities 67,561,000
2 Expenses 71,078,501
3 Revenues 27,761,563
4 StockholdersEquity 27,929,000
5 NetIncome -33,376,814
6 ComprehensiveNetIncome -33,516,261
7 BaseVar 136,055,041
8 EconomicCapitalRatiobeforeLimitedLiability 0.336
9 EconomicCapitalRatio 1.73

Edgar->Model Mapping

Feature Distribution

Change over Time